The elevated levels of FC in patients with MASLD/MASH were attributed to enhanced HMGCR activity resulting in increased synthesis, as opposed to alterations in the uptake of cholesterols through LDL-R or reductions in the synthesis/export of bile [132]. The gene discussed is LDLR; the disease is metabolic dysfunction-associated steatohepatitis.